x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

COR2ED - Oncology Medical Conversation

COR2ED Medical Education

Join oncology experts as they discuss their approaches to diagnosing and managing patients with gastrointestinal, genitourinary, lung, breast, gynecological, neuroendocrine and hematological cancers, sarcomas, and more. The conversations also explore cutting edge developments in precision oncology, as well as emerging treatments, including immunotherapy. This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit

science courses

All Episodes

00:27:12

Intermediate HCC – The evolving role of IO

COR2ED - Oncology Medical Conversation ·

2025/01/20

Intermediate HCC – The evolving role of IO In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology Brothers Drs Rohit and Rahul Gosain, the discussion focuses on the evolving role of immunotherapy (IO) in intermediate HCC. The episode explores multimodal approaches that combine IO and IO-based therapies with loco-regional treatments and highlights the essential role of a multidisciplinary care team. Joined by Drs Nina Sanford

en

00:27:12

Intermediate HCC – The evolving role of IO

COR2ED - Oncology Medical Conversation ·

2025/01/20

Intermediate HCC – The evolving role of IO In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology Brothers Drs Rohit and Rahul Gosain, the discussion focuses on the evolving role of immunotherapy (IO) in intermediate HCC. The episode explores multimodal approaches that combine IO and IO-based therapies with loco-regional treatments and highlights the essential role of a multidisciplinary care team. Joined by Drs Nina Sanford

en

00:20:19

Intermediate HCC – treatment options and strategies

COR2ED - Oncology Medical Conversation ·

2025/01/07

In the third of this 4-part podcast series on HCC, the Oncology Brothers Dr Rahul and Dr Rohit Gosain are joined by Hepatologist Dr Maria Reig and Interventional Radiologist Dr Emil Cohen to explore the complexities of managing intermediate-stage hepatocellular carcinoma (HCC). Together, they unpack treatment options and strategies through a dynamic and engaging discussion rooted in real-world clinical practice. Key topics include: An overview of the available treatment

en

00:20:19

Intermediate HCC – treatment options and strategies

COR2ED - Oncology Medical Conversation ·

2025/01/07

In the third of this 4-part podcast series on HCC, the Oncology Brothers Dr Rahul and Dr Rohit Gosain are joined by Hepatologist Dr Maria Reig and Interventional Radiologist Dr Emil Cohen to explore the complexities of managing intermediate-stage hepatocellular carcinoma (HCC). Together, they unpack treatment options and strategies through a dynamic and engaging discussion rooted in real-world clinical practice. Key topics include: An overview of the available treatment

en

00:26:18

HCC podcast series part 2: 2nd line treatment in...

COR2ED - Oncology Medical Conversation ·

2024/12/03

Join the Oncology Brothers, Drs Rahul and Rohit Gosain, as they host an insightful discussion with Dr Lorenza Rimassa and Prof. Arndt Vogel. In the second of a 4-part podcast series, this episode dives into 2nd line treatment selection in advanced HCC and the key considerations for deciding when to switch therapies. Topics include: 2nd line options for advanced HCC after 1st line TKIs and IO-based therapies Sequencing strategies and clinical practice approaches Key

en

00:26:18

HCC podcast series part 2: 2nd line treatment in...

COR2ED - Oncology Medical Conversation ·

2024/12/03

Join the Oncology Brothers, Drs Rahul and Rohit Gosain, as they host an insightful discussion with Dr Lorenza Rimassa and Prof. Arndt Vogel. In the second of a 4-part podcast series, this episode dives into 2nd line treatment selection in advanced HCC and the key considerations for deciding when to switch therapies. Topics include: 2nd line options for advanced HCC after 1st line TKIs and IO-based therapies Sequencing strategies and clinical practice approaches Key

en

00:23:25

Testing to treatment of BRAF-mutant metastatic NSCLC

COR2ED - Oncology Medical Conversation ·

2024/11/25

Testing to treatment of BRAF-mutant metastatic NSCLC In this educational podcast episode, experts Prof. David Planchard and Dr Federico Cappuzzo discuss the significance of BRAF mutations in metastatic non-small cell lung cancer (NSCLC), the testing strategies and first- and second-line treatment options for these patients. The discussion focuses on which BRAF mutations to test for and when in the patient journey to test, before moving on to consider if NGS broad panel

en

00:23:25

Testing to treatment of BRAF-mutant metastatic NSCLC

COR2ED - Oncology Medical Conversation ·

2024/11/25

Testing to treatment of BRAF-mutant metastatic NSCLC In this educational podcast episode, experts Prof. David Planchard and Dr Federico Cappuzzo discuss the significance of BRAF mutations in metastatic non-small cell lung cancer (NSCLC), the testing strategies and first- and second-line treatment options for these patients. The discussion focuses on which BRAF mutations to test for and when in the patient journey to test, before moving on to consider if NGS broad panel

en

00:23:21

HCC podcast series part 1: The use of IO in...

COR2ED - Oncology Medical Conversation ·

2024/11/21

In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use of IO (immunotherapy) in unresectable HCC (uHCC) and take a deep dive into the different treatment options first-line focusing on IO and IO based combinations. Topics include: Current first-line systemic treatment options for uHCC Efficacy and safety of IO and IO combinations including practical aspects of identifying and managing

en

00:25:50

BRAF-mutated CRC: testing to treatment

COR2ED - Oncology Medical Conversation ·

2024/11/08

Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available treatments for these patients. They consider the prevalence and types of BRAF mutations in CRC patients and highlight the poor prognosis for these patients. The experts also cover the optimal time and methods for testing for BRAF mutations, as well as the targeted therapies currently available for BRAF-mutated

en

00:25:50

BRAF-mutated CRC: testing to treatment

COR2ED - Oncology Medical Conversation ·

2024/11/08

Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available treatments for these patients. They consider the prevalence and types of BRAF mutations in CRC patients and highlight the poor prognosis for these patients. The experts also cover the optimal time and methods for testing for BRAF mutations, as well as the targeted therapies currently available for BRAF-mutated

en

00:22:51

Neuroendocrine tumours (NETs) – Shared...

COR2ED - Oncology Medical Conversation ·

2024/09/11

In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins explore shared decision-making, between patient and physician.The speakers discuss different treatment settings, including home vs hospital-based injections, as well as the importance of individualising treatment decisions, as there is often no standard therapy for patients with NETs. Finally, they look at some of the studies reporting

en

00:22:51

Neuroendocrine tumours (NETs) – Shared...

COR2ED - Oncology Medical Conversation ·

2024/09/11

In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins explore shared decision-making, between patient and physician. The speakers discuss different treatment settings, including home vs hospital-based injections, as well as the importance of individualising treatment decisions, as there is often no standard therapy for patients with NETs. Finally, they look at some of

en

00:29:55

Neuroendocrine tumours (NETs) – Shared...

COR2ED - Oncology Medical Conversation ·

2024/09/11

In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins discuss the importance of communication and collaboration during consultations. This can include how to make a patient feel as comfortable and in control as possible, as well as recognising their goals and concerns. The speakers share their real-life experiences of what makes a good consultation, from the perspectives

en

00:29:55

Neuroendocrine tumours (NETs) – Shared...

COR2ED - Oncology Medical Conversation ·

2024/09/11

In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins discuss the importance of communication and collaboration during consultations. This can include how to make a patient feel as comfortable and in control as possible, as well as recognising their goals and concerns. The speakers share their real-life experiences of what makes a good consultation, from the perspectives of both a patient and a

en

00:21:16

Regional differences in NET: Treatment and future...

COR2ED - Oncology Medical Conversation ·

2024/05/28

In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living with NETs and future developments in the field which may help to improve patient outcomes. The episode includes information on different treatment options and modalities, and well as best practice on identifying which patients may benefit most from particular treatments using available biomarkers. Prof. Martyn Caplin is

en

00:21:16

Regional differences in NET: Treatment and future...

COR2ED - Oncology Medical Conversation ·

2024/05/28

In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living with NETs and future developments in the field which may help to improve patient outcomes. The episode includes information on different treatment options and modalities, and well as best practice on identifying which patients may benefit most from particular treatments using available biomarkers.Prof. Martyn Caplin is Professor of

en

00:21:47

Regional differences in NET: Epidemiology, diagnosis,...

COR2ED - Oncology Medical Conversation ·

2024/05/28

In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient pathways, as well as look to future developments. NETs are complex, rare diseases. Their optimal management and treatment requires early diagnosis, shared decision-making, and timely referral. The best possible patient journey is impacted by regional differences in management strategies, referral pathways, and

en

00:21:47

Regional differences in NET: Epidemiology, diagnosis,...

COR2ED - Oncology Medical Conversation ·

2024/05/28

In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient pathways, as well as look to future developments. NETs are complex, rare diseases. Their optimal management and treatment requires early diagnosis, shared decision-making, and timely referral. The best possible patient journey is impacted by regional differences in management strategies, referral pathways, and availability of diagnostic

en

00:25:30

Understanding the needs of different patient...

COR2ED - Oncology Medical Conversation ·

2024/05/15

Do you understand the needs of different patient groups with colorectal cancer? Do you know about the barriers to treatment experienced by different ethnicities, socioeconomic groups and younger patients? In this insightful podcast facilitated by Oncology Brothers Drs Rahul and Rohit Gosain, Prof Tanios Bekaii-Saab and Ms Deneen Richmond provide their perspectives as a practising oncologist and a cancer survivor. They discuss the different methods of communication required to

en

181 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter